VUNO said on Wednesday that a multi-institutional study demonstrated the cardiac arrest predictive performance of VUNO Med-DeepCARS to monitor the risk of severe deterioration of pediatric inpatients when doctors and nurses were not around.

The screenshot shows the VUNO Med-DeepCARS operation screen which can aid physicians in predicting cardiac arrest to improve clinical outcomes for hospitalized patients.
The screenshot shows the VUNO Med-DeepCARS operation screen which can aid physicians in predicting cardiac arrest to improve clinical outcomes for hospitalized patients.

Previous studies show that the number of cardiopulmonary resuscitations (CPR) performed in hospitals for children and adolescents in Korea increased from 806 in 2010 to 913 in 2019. Meanwhile, the survival rate of pediatric and adolescent patients who have undergone CPR over the past decade has shown a decline from 34 percent to 32.3 percent with climbing medical expenses.

Due to the rapid decline in the population of children and the shortage of doctors and nurses, it is urgent to prepare countermeasures to improve clinical outcomes and the safe management of inpatients, VUNO said.

The study, led by Professor Jhang Won-kyoung's team at Asan Medical Center in Seoul, verified the predictive performance of VUNO Med-DeepCARS in children under the age of 19 hospitalized at five tertiary medical institutions.

Accordingly, VUNO Med-DeepCARS demonstrated excellent performance in all evaluation indicators such as in-hospital cardiac arrest (IHCA), unexpected general ward-to-pediatric intensive care unit transfer UIT prediction accuracy, and false alarm rates with only four essential vital signs.

Additionally, even though the frequency of cardiac arrest in the front room of the intensive care unit or the hospital was different for each medical institution participating in the study, all institutions confirmed high predictive accuracy and low false alarm rates, the study said.

Furthermore, it was found to be effective regardless of the patient's age, gender, and occurrence time.

"Through multi-institutional verification, this study proved that VUNO Med-DeepCARS effectively predicts hospitalized patients under the age of 19 while confirming the high versatility of the product," said VUNO CEO Lee Ye-ha.

The study was published in the Acute and Critical Care (ACC) journal.

Copyright © KBR Unauthorized reproduction, redistribution prohibited